AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32664934 — intervention group
Group type: COMPARATOR
Intervention: Control period (no intervention)
Number of subjects: 6172
Study 35794811 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based vestibular rehabilitation therapy (Bal Ex)
Number of subjects: 30
Study 35794811 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based vestibular rehabilitation therapy (control)
Number of subjects: 30
Study 34922713 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable partial denture (RPD) for replacement of missing molars (n=79)
Number of subjects: 150
Study 34922713 — intervention group
Group type: COMPARATOR
Intervention: Shortened dental arch (SDA) without molar replacement (n=71)
Number of subjects: 150
Study 32345707 — intervention group
Group type: EXPERIMENTAL
Intervention: Plan Well Guide (intervention group)
Number of subjects: 123
Study 32345707 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 123
Study 33790161 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (1,000 mg/m2) and Cisplatin (40 mg/m2) on days 1 and 15, and Bevacizumab (15 mg/kg) on day 1, repeated every 4 weeks
Number of subjects: 6
Study 33790161 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus Cisplatin plus Bevacizumab combination chemotherapy
Number of subjects: 6
Study 33225971 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow (NHF) at 1.5 L/kg PBW/min (75–120 L/min)
Number of subjects: 12
Study 34994945 — intervention group
Group type: EXPERIMENTAL
Intervention: Reach Plus
Number of subjects: 161
Study 34994945 — intervention group
Group type: EXPERIMENTAL
Intervention: Reach Plus Message
Number of subjects: 161
Study 34994945 — intervention group
Group type: EXPERIMENTAL
Intervention: Reach Plus Phone
Number of subjects: 161
Study 33904977 — intervention group
Group type: EXPERIMENTAL
Intervention: Open total adventitial resection of the cardia (TARC), n = 45
Number of subjects: 198
Study 33904977 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Ivor Lewis oesophagectomy (HILO), n = 50
Number of subjects: 198
Study 33904977 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic‐thoracoscopic assisted (LTA), n = 56
Number of subjects: 198
Study 33904977 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally minimally invasive TARC (TMI TARC), n = 47
Number of subjects: 198
Study 33904977 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 198
Study 35174901 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel mechanical compression device (PressRite, PR)
Number of subjects: 105
Study 35174901 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 105
Study 34343414 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused Attention Meditation (FAM)
Number of subjects: 30
Study 34343414 — intervention group
Group type: COMPARATOR
Intervention: Random thinking (Control)
Number of subjects: 30
Study 34800819 — intervention group
Group type: EXPERIMENTAL
Intervention: OJ (orange juice containing 345 mg of hesperidin; n=15)
Number of subjects: 37
Study 34800819 — intervention group
Group type: EXPERIMENTAL
Intervention: EOJ (enhanced orange juice containing 600 mg of hesperidin; n=11)
Number of subjects: 37
Study 34800819 — intervention group
Group type: COMPARATOR
Intervention: CD (control drink; n=11)
Number of subjects: 37
Study 34800819 — intervention group
Group type: EXPERIMENTAL
Intervention: EOJ
Number of subjects: 37
Study 32633157 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with reduced calcineurin inhibitor (EVR+rCNI)
Number of subjects: 2026
Study 32633157 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolic acid plus standard-exposure CNI (MPA+sCNI)
Number of subjects: 2026
Study 35641048 — intervention group
Group type: EXPERIMENTAL
Intervention: Telepsychiatry collaborative care
Number of subjects: 12
Study 35641048 — intervention group
Group type: COMPARATOR
Intervention: Referral approach
Number of subjects: 12
Study 34358497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg and lamivudine 300 mg once daily
Number of subjects: 265
Study 34358497 — intervention group
Group type: COMPARATOR
Intervention: Triple ART
Number of subjects: 265
Study 34358497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir plus lamivudine
Number of subjects: 265
Study 32032954 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral cZi DBS
Number of subjects: 25
Study 32032954 — intervention group
Group type: COMPARATOR
Intervention: Best Medical Treatment (BMT)
Number of subjects: 25
Study 35283398 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss in the first quartile (median change -1.02 kg)
Number of subjects: 404
Study 35283398 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss in the second quartile (median change -0.25 kg)
Number of subjects: 404
Study 35283398 — intervention group
Group type: COMPARATOR
Intervention: Weight loss in the third quartile (median change +0.26 kg)
Number of subjects: 404
Study 35283398 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss in the fourth quartile (median change +0.86 kg)
Number of subjects: 404
Study 32331737 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 27
Study 32331737 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural ointment based on honey-tea tree oil
Number of subjects: 27
Study 36000709 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-determination theory (SDT)‐guided dental education (three face‐to‐face educational sessions)
Number of subjects: 196
Study 36000709 — intervention group
Group type: COMPARATOR
Intervention: Conventional dental instruction (one session)
Number of subjects: 196
Study 36000709 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-determination theory (SDT)‐guided dental education
Number of subjects: 196
Study 33665839 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus study interventions
Number of subjects: 123
Study 33665839 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 123
Study 35007787 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention with run-in procedures (food diary completion, questionnaire completion, staff interview)
Number of subjects: 0
Study 35007787 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicted moderate adherers
Number of subjects: 0
Study 35007787 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicted low adherers
Number of subjects: 0
Study 35007787 — intervention group
Group type: EXPERIMENTAL
Intervention: Run-in data
Number of subjects: 0
Study 33751522 — intervention group
Group type: EXPERIMENTAL
Intervention: Galactagogue Group (barley malt-based composition with β-glucan and lemon balm)
Number of subjects: 117
Study 33751522 — intervention group
Group type: EXPERIMENTAL
Intervention: Galactagogue Group
Number of subjects: 117
Study 33751522 — intervention group
Group type: COMPARATOR
Intervention: Placebo Group
Number of subjects: 117
Study 34789480 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab plus axitinib
Number of subjects: 0
Study 34789480 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 0
Study 34536960 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia crowns (ZC)
Number of subjects: 45
Study 34536960 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel crowns (SSC)
Number of subjects: 45
Study 34536960 — intervention group
Group type: COMPARATOR
Intervention: Strip crowns (SC)
Number of subjects: 45
Study 34536960 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent and child satisfaction
Number of subjects: 45
Study 34653814 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial scratching (twice endometrial sampling in follicular and luteal phases)
Number of subjects: 20
Study 34653814 — intervention group
Group type: COMPARATOR
Intervention: Control group (only luteal phase sampling)
Number of subjects: 20
Study 32398726 — intervention group
Group type: EXPERIMENTAL
Intervention: Urolithin metabotypes (UM-B or UM-0)
Number of subjects: 415
Study 32398726 — intervention group
Group type: EXPERIMENTAL
Intervention: Low KIDMED score
Number of subjects: 415
Study 32398726 — intervention group
Group type: EXPERIMENTAL
Intervention: Consortium of 24 SNPs (including rs1801253-ADRB1, rs4343-ACE, rs8061518-FTO, rs1130864-CRP, rs659366-UCP2, rs6131-SELP, rs12535708-LEP, rs1501299-ADIPOQ, rs708272-CETP, rs2241766-ADIPOQ)
Number of subjects: 415
Study 34110861 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Match System
Number of subjects: 218
Study 34110861 — intervention group
Group type: COMPARATOR
Intervention: Usual assignment
Number of subjects: 218
Study 34831644 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self‐testing infographic intervention
Number of subjects: 322
Study 34831644 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 322
Study 33145856 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorations planted with species-rich seed mixes
Number of subjects: 93
Study 33145856 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher organic matter and more linear shape
Number of subjects: 93
Study 33145856 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of planting
Number of subjects: 93
Study 33145856 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of exotic species
Number of subjects: 93
Study 33327326 — intervention group
Group type: EXPERIMENTAL
Intervention: Peony and licorice decoction (PLD) fumigation treatment
Number of subjects: 190
Study 33327326 — intervention group
Group type: COMPARATOR
Intervention: Placebo fumigation treatment
Number of subjects: 190
Study 33327326 — intervention group
Group type: EXPERIMENTAL
Intervention: PLD fumigation treatment
Number of subjects: 190
Study 33906081 — intervention group
Group type: EXPERIMENTAL
Intervention: kMCT (30 g/day)
Number of subjects: 39
Study 33906081 — intervention group
Group type: COMPARATOR
Intervention: Placebo (calorie-matched)
Number of subjects: 39
Study 33123219 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment for 12 months
Number of subjects: 118
Study 33772749 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral intervention (provider-focused alerts and patient-focused video)
Number of subjects: 552
Study 32502445 — intervention group
Group type: EXPERIMENTAL
Intervention: Open radical hysterectomy
Number of subjects: 631
Study 32502445 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive radical hysterectomy
Number of subjects: 631
Study 34942085 — intervention group
Group type: EXPERIMENTAL
Intervention: Elexacaftor 200 mg orally once daily plus tezacaftor 100 mg orally once daily plus ivacaftor 150 mg orally every 12 h
Number of subjects: 176
Study 34942085 — intervention group
Group type: COMPARATOR
Intervention: Tezacaftor 100 mg orally once daily plus ivacaftor 150 mg orally every 12 h
Number of subjects: 176
Study 32282494 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular tenderness
Number of subjects: 217
Study 32282494 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure points
Number of subjects: 217
Study 36241051 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant via Laryngeal Mask Airway (LMA)
Number of subjects: 93
Study 36241051 — intervention group
Group type: COMPARATOR
Intervention: Surfactant via Endotracheal Tube (ETT)
Number of subjects: 93
Study 34077535 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT + prescription medication
Number of subjects: 6285
Study 34077535 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone + In Person
Number of subjects: 6285
Study 34077535 — intervention group
Group type: COMPARATOR
Intervention: Reasons for declining enrollment
Number of subjects: 6285
Study 34580067 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 334
Study 34580067 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 334
Study 34580067 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT+yoga
Number of subjects: 334
Study 34580067 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 334
Study 33861306 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stable SBP trajectory
Number of subjects: 0
Study 33861306 — intervention group
Group type: EXPERIMENTAL
Intervention: High stable SBP trajectory
Number of subjects: 0
Study 32725447 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular-focused treatment with feedback (SFTF)
Number of subjects: 75
Study 32725447 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular-focused treatment without feedback (SFT)
Number of subjects: 75
Study 32725447 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 32045868 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based exergaming
Number of subjects: 60
Study 32045868 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation
Number of subjects: 60
Study 32045868 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 35536104 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-compliant (RC) group
Number of subjects: 125
Study 35536104 — intervention group
Group type: COMPARATOR
Intervention: Non–RT-compliant (NRC) group
Number of subjects: 125
Study 32699034 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg intravenous every 4 weeks
Number of subjects: 93
Study 32699034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 34913216 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper voucher described as redeemable for free follow-up and prescription glasses
Number of subjects: 821
Study 34913216 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper voucher with monetary value indication ($250)
Number of subjects: 821
Study 34913216 — intervention group
Group type: COMPARATOR
Intervention: Standard referral for a free follow-up appointment and prescription glasses
Number of subjects: 821
Study 33731062 — intervention group
Group type: EXPERIMENTAL
Intervention: Active study product (combination of Bifidobacterium breve M‐16V, short‐chain galacto‐oligosaccharides, long‐chain fructo‐oligosaccharides and L‐glutamine)
Number of subjects: 88
Study 33731062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 34750775 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit Sexual Risk Assessment (ISRA)
Number of subjects: 79
Study 34750775 — intervention group
Group type: COMPARATOR
Intervention: Balloon Analogue Risk Task (BART)
Number of subjects: 79
Study 34750775 — intervention group
Group type: COMPARATOR
Intervention: BART and ISRA
Number of subjects: 79
Study 34750775 — intervention group
Group type: COMPARATOR
Intervention: Sexual arousal
Number of subjects: 79
Study 33828238 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted selenium
Number of subjects: 1000000
Study 32023537 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based muscle power training intervention
Number of subjects: 12
Study 32023537 — intervention group
Group type: COMPARATOR
Intervention: Step-monitoring comparison group
Number of subjects: 12
Study 35652362 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-vision (MV)‐based dynamic navigation (DN)
Number of subjects: 24
Study 35652362 — intervention group
Group type: COMPARATOR
Intervention: Control (freehand technique)
Number of subjects: 24
Study 36191117 — intervention group
Group type: EXPERIMENTAL
Intervention: SwasthGarbh App
Number of subjects: 150
Study 34242463 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Access Pathway (TAP)
Number of subjects: 181
Study 34242463 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 181
Study 33428832 — intervention group
Group type: EXPERIMENTAL
Intervention: Face coverings
Number of subjects: 0
Study 35292336 — intervention group
Group type: EXPERIMENTAL
Intervention: Holistic-thinking group with positive affect
Number of subjects: 44
Study 35292336 — intervention group
Group type: EXPERIMENTAL
Intervention: Analytic-thinking group with positive affect
Number of subjects: 44
Study 35292336 — intervention group
Group type: EXPERIMENTAL
Intervention: Analytic-thinking group with negative affect
Number of subjects: 44
Study 35292336 — intervention group
Group type: EXPERIMENTAL
Intervention: Holistic-thinking group with negative affect
Number of subjects: 44
Study 33726984 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 1014
Study 33726984 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users (PSM cohort)
Number of subjects: 1014
Study 33726984 — intervention group
Group type: COMPARATOR
Intervention: Statin non-users (PSM cohort)
Number of subjects: 1014
Study 32575450 — intervention group
Group type: EXPERIMENTAL
Intervention: Harvesting at week 16 with 1st harvest frequency
Number of subjects: 0
Study 32575450 — intervention group
Group type: EXPERIMENTAL
Intervention: Harvesting age (week 8, 12, and 16)
Number of subjects: 0
Study 32575450 — intervention group
Group type: EXPERIMENTAL
Intervention: Harvesting frequency (harvest 1, 2, and 3)
Number of subjects: 0
Study 32575450 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive compounds (shaftoside, iso‐orientin, and orientin)
Number of subjects: 0
Study 33191527 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior cycling exercise (1 hour at 70-75% V̇O2peak)
Number of subjects: 8
Study 33191527 — intervention group
Group type: COMPARATOR
Intervention: High-glucose mixed-nutrient meal ingestion (1.1 g glucose/kg body weight; 45% carbohydrate, 20% protein, 35% fat)
Number of subjects: 8
Study 33191527 — intervention group
Group type: COMPARATOR
Intervention: Control (no-exercise)
Number of subjects: 8
Study 33271093 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV 16/18 AS04‐adjuvanted vaccine
Number of subjects: 7466
Study 33271093 — intervention group
Group type: COMPARATOR
Intervention: Control hepatitis A vaccine
Number of subjects: 7466
Study 35587890 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Coaching (HC)
Number of subjects: 200
Study 35587890 — intervention group
Group type: COMPARATOR
Intervention: Standardized Risk Assessment (SRA)
Number of subjects: 200
Study 33150850 — intervention group
Group type: EXPERIMENTAL
Intervention: Home based exercise program with activity tracking device, personalized feedback, and financial incentives
Number of subjects: 41
Study 33150850 — intervention group
Group type: EXPERIMENTAL
Intervention: Home based exercise program with activity tracking device and personalized feedback
Number of subjects: 41
Study 33150850 — intervention group
Group type: COMPARATOR
Intervention: Control group with activity monitoring device but no feedback
Number of subjects: 41
Study 34553964 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 557
Study 34553964 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Care (SC) + Contingency Management (CM)
Number of subjects: 557
Study 34553964 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 557
Study 33433136 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiating discussions about DNR with patients' families
Number of subjects: 0
Study 33433136 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiating discussions about DNR with patients
Number of subjects: 0
Study 33433136 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiences of actively initiating DNR discussions with patients
Number of subjects: 0
Study 33433136 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiences of actively initiating DNR discussions with patients' families
Number of subjects: 0
Study 33433136 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted factors
Number of subjects: 0
Study 36170326 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amino acid challenge (AAC)
Number of subjects: 9
Study 36170326 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric glucose solution (GS)
Number of subjects: 9
Study 33378082 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazardous drinking
Number of subjects: 241
Study 33378082 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate impulsivity
Number of subjects: 241
Study 33378082 — intervention group
Group type: EXPERIMENTAL
Intervention: High impulsivity
Number of subjects: 241
Study 33378082 — intervention group
Group type: EXPERIMENTAL
Intervention: Impulsivity
Number of subjects: 241
Study 33378082 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazardous drinking and impulsivity
Number of subjects: 241
Study 34931782 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 14
Study 34931782 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 14
Study 34931782 — intervention group
Group type: COMPARATOR
Intervention: Sedentary Control (CON)
Number of subjects: 14
Study 32066431 — intervention group
Group type: EXPERIMENTAL
Intervention: 5° conical internal hexed connection (Anyridge®, MegaGen, South Korea)
Number of subjects: 104
Study 32066431 — intervention group
Group type: COMPARATOR
Intervention: internal hexed connection (Core®, Kristal, Italy)
Number of subjects: 104
Study 36394566 — intervention group
Group type: EXPERIMENTAL
Intervention: PaFein teaching model (9 hours course)
Number of subjects: 172
Study 34470624 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced measurement-based care (eMBC) using digital technologies
Number of subjects: 417
Study 34470624 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard measurement-based care (MBC)
Number of subjects: 417
Study 32157126 — intervention group
Group type: EXPERIMENTAL
Intervention: Twist tube (group T)
Number of subjects: 86
Study 32157126 — intervention group
Group type: COMPARATOR
Intervention: Conventional tube (group C)
Number of subjects: 86
Study 33994142 — intervention group
Group type: EXPERIMENTAL
Intervention: Slowness in Eating
Number of subjects: 322
Study 33994142 — intervention group
Group type: EXPERIMENTAL
Intervention: Satiety Responsiveness
Number of subjects: 322
Study 33994142 — intervention group
Group type: EXPERIMENTAL
Intervention: Enjoyment of Food
Number of subjects: 322
Study 36116950 — intervention group
Group type: EXPERIMENTAL
Intervention: Milled bases (MB1)
Number of subjects: 20
Study 36116950 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed bases (PB1)
Number of subjects: 20
Study 36116950 — intervention group
Group type: COMPARATOR
Intervention: Conventional bases (CB)
Number of subjects: 20
Study 32215135 — intervention group
Group type: EXPERIMENTAL
Intervention: PELD combined with PEEK rod
Number of subjects: 243
Study 32215135 — intervention group
Group type: COMPARATOR
Intervention: PELD
Number of subjects: 243